全膝关节置换术后甲泼尼龙递减方案:前瞻性单盲随机试验
该前瞻性单盲随机对照试验纳入69例因骨关节炎行初次全膝关节置换术的患者,比较标准多模式镇痛方案联合6天口服甲泼尼龙递减方案(MPT)与单纯标准方案的效果。结果显示MPT组术后第1天恶心评分显著降低(P<0.05),阿片类药物消耗和疼痛评分有降低趋势但未达统计学显著性,且未增加并发症,膝关节活动度变化两组相当。
要点
- MPT组术后第1天恶心水平显著低于对照组(P<0.05)。
- MPT组术后第一周累积口服吗啡当量均值95.5 vs 116.9,差异无统计学显著性。
- 两组并发症无增加,3个月膝关节活动度变化相当。
核心结论
- 在初次全膝关节置换术后的多模式镇痛方案中加入6天口服甲泼尼龙递减方案,可显著降低术后第1天恶心水平。
- MPT组疼痛评分和阿片类药物消耗呈降低趋势但未达统计学显著性,且未增加并发症。
研究设计与样本
- 前瞻性单盲随机对照试验,纳入因骨关节炎行初次全膝关节置换术的患者69例,对照组34例,MPT组35例。
- 患者随机接受标准多模式镇痛方案或该方案联合6天口服甲泼尼龙递减方案(Medrol Dosepak)。
- 收集术后7天疼痛和恶心视觉模拟评分及阿片类药物消耗数据,术前和术后3个月随访收集膝关节活动度。
主要发现
- MPT组术后第1天恶心水平显著降低(P<0.05)。
- MPT组术后第一周每日和累积口服吗啡当量降低,平均累积口服吗啡当量95.5 vs 116.9,但未达统计学显著性。
- 两组大多数患者在术后第7天前停止使用阿片类药物。
- MPT组疼痛评分较低但无统计学显著性,MPT组未见并发症增加。
- 两组膝关节活动度变化相当。
关键数值与推荐
- MPT组术后第1天恶心水平显著降低(P<0.05)。
- 平均累积口服吗啡当量MPT组95.5 vs 对照组116.9,差异无统计学显著性。
临床怎么用
- 对于初次全膝关节置换术后患者,可考虑在多模式镇痛方案中加入6天口服甲泼尼龙递减方案以减轻术后早期恶心。
- 该方案未增加并发症,但疼痛和阿片类药物消耗的降低趋势未达统计学显著性,需结合患者个体情况权衡使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of short-term postoperative corticosteroid regimens has been reported to improve pain control and decrease opioid consumption following total knee arthroplasty (TKA). The purpose of this study was to evaluate the effect of a methylprednisolone taper (MPT) on reducing patients' subjective pain levels and opioid consumption in the early postoperative period following primary TKA. METHODS: This was a prospective single-blinded randomized controlled trial of patients undergoing primary TKA for osteoarthritis. Patients were randomized to receive a standardized multimodal pain control regimen alone or the same regimen with a 6-day oral MPT (i.e., Medrol Dosepak). Patient pain and nausea Visual Analog Scale scores, as well as opioid consumption data, were collected for 7 days, while knee range of motion was collected preoperatively and at the 3-month follow-up visit. An a priori power analysis was conducted, and 69 patients were enrolled from October 2023 to March 2025, with 34 randomized into the control group and 35 into the MPT group. RESULTS: Patients in the MPT group reported significantly decreased nausea levels on postoperative day 1 (P < 0.05). Daily and cumulative oral morphine equivalents were decreased in the MPT group over the first postoperative week, with a mean cumulative oral morphine equivalent of 95.5 versus 116.9, though this did not reach statistical significance. The majority of patients stopped opioids by day 7 in both groups. Pain scores were lower, but not significantly so, in the MPT group. There were no increased complications seen in the MPT group. Range of motion changes were equivalent between groups. CONCLUSIONS: This randomized controlled trial demonstrated a significant reduction in nausea levels on postoperative day 1 and a nonsignificant trend toward reduced pain and opioid use with a 6-day MPT following primary TKA for osteoarthritis in the context of a multimodal postoperative regimen. Importantly, we observed no increased complications with the use of an MPT.
引用
- Premkumar A, Arellano E, Heo KY, et al. Methylprednisolone Taper After Total Knee Arthroplasty: A Prospective Single-Blinded Randomized Trial. J Arthroplasty. 2026. PMID: 42036080. doi:10.1016/j.arth.2026.04.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。